These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2288877)

  • 1. Transforming growth factor beta 1 acts as an autocrine-negative growth regulator in colon enterocytic differentiation but not in goblet cell maturation.
    Hafez MM; Infante D; Winawer S; Friedman E
    Cell Growth Differ; 1990 Dec; 1(12):617-26. PubMed ID: 2288877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two roles for transforming growth factor beta 1 in colon enterocytic cell differentiation.
    Hafez MM; Hsu S; Yan Z; Winawer S; Friedman E
    Cell Growth Differ; 1992 Nov; 3(11):753-62. PubMed ID: 1334691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colon carcinoma cells switch their response to transforming growth factor beta 1 with tumor progression.
    Hsu S; Huang F; Hafez M; Winawer S; Friedman E
    Cell Growth Differ; 1994 Mar; 5(3):267-75. PubMed ID: 8018559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of transforming growth factor beta 1 in induction of colon carcinoma differentiation by hexamethylene bisacetamide.
    Schroy P; Rifkin J; Coffey RJ; Winawer S; Friedman E
    Cancer Res; 1990 Jan; 50(2):261-5. PubMed ID: 2295065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.
    Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E
    Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III.
    Deng X; Bellis S; Yan Z; Friedman E
    Cell Growth Differ; 1999 Jan; 10(1):11-8. PubMed ID: 9950213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine transforming growth factor-beta 1 and beta 2 expression is increased by cell crowding and quiescence in colon carcinoma cells.
    Sun L; Wu S; Coleman K; Fields KC; Humphrey LE; Brattain MG
    Exp Cell Res; 1994 Sep; 214(1):215-24. PubMed ID: 8082724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor beta 1 (TGF-beta 1) inhibits retinoblastoma gene expression but not pRB phosphorylation in TGF-beta 1-growth stimulated colon carcinoma cells.
    Yan Z; Hsu S; Winawer S; Friedman E
    Oncogene; 1992 Apr; 7(4):801-5. PubMed ID: 1565477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of transforming growth factor alpha expression by transforming growth factor beta 1, epidermal growth factor, and N,N-dimethylformamide in human colon carcinoma cells.
    Zipfel PA; Ziober BL; Morris SL; Mulder KM
    Cell Growth Differ; 1993 Aug; 4(8):637-45. PubMed ID: 8398905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of nm23 in transforming growth factor beta 1-mediated adherence and growth arrest.
    Hsu S; Huang F; Wang L; Banerjee S; Winawer S; Friedman E
    Cell Growth Differ; 1994 Sep; 5(9):909-17. PubMed ID: 7819128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
    Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK
    Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
    Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM
    Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repression of autocrine transforming growth factor beta 1 and beta 2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties.
    Wu SP; Sun LZ; Willson JK; Humphrey L; Kerbel R; Brattain MG
    Cell Growth Differ; 1993 Feb; 4(2):115-23. PubMed ID: 8494782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of transforming growth factor beta 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines.
    Cohen PS; Letterio JJ; Gaetano C; Chan J; Matsumoto K; Sporn MB; Thiele CJ
    Cancer Res; 1995 Jun; 55(11):2380-6. PubMed ID: 7757990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1.
    Picon A; Gold LI; Wang J; Cohen A; Friedman E
    Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):497-504. PubMed ID: 9641494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretion of transforming growth factor-beta isoforms by embryonic stem cells: isoform and latency are dependent on direction of differentiation.
    Slager HG; Freund E; Buiting AM; Feijen A; Mummery CL
    J Cell Physiol; 1993 Aug; 156(2):247-56. PubMed ID: 8344983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells.
    Rodeck U; Bossler A; Graeven U; Fox FE; Nowell PC; Knabbe C; Kari C
    Cancer Res; 1994 Jan; 54(2):575-81. PubMed ID: 8275496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
    Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
    Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colon absorptive epithelial cells lose proliferative response to TGF alpha as they differentiate.
    Huang F; Sauma S; Yan Z; Friedman E
    Exp Cell Res; 1995 Jul; 219(1):8-14. PubMed ID: 7628553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer.
    Brunschwig EB; Wilson K; Mack D; Dawson D; Lawrence E; Willson JK; Lu S; Nosrati A; Rerko RM; Swinler S; Beard L; Lutterbaugh JD; Willis J; Platzer P; Markowitz S
    Cancer Res; 2003 Apr; 63(7):1568-75. PubMed ID: 12670906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.